AlphaStocks
3.2
Weak

Prestige Consumer Healthcare Inc. (PBH)

As of Sep 20, 2026, Prestige Consumer Healthcare Inc. (PBH) scores 3.2/10 on AlphaStocks' five-model composite, #155 of 168 Health Care stocks.

Health Care / Pharmaceuticals

S&P SmallCap 600

$44.95

Scores poorly across most models. Proceed with caution.

Weak

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#155out of 168 in Health Care

Is Prestige Consumer Healthcare Inc. a Good Investment in 2026?

Prestige Consumer Healthcare Inc. (PBH) scores 3.2 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Greenblatt Magic Formula model rates Prestige Consumer Healthcare Inc. as Strong (Earnings yield 9.3% · ROC 72%). The Lynch model is the least favorable, rating it Neutral. Prestige Consumer Healthcare Inc. ranks #155 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E11.5ROE10.2Market Cap2B

Valuation

Trades at 12x earnings — near sector median of 30x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

16% below fair value

Lynch

Neutral

PEG 0.9 · Fast Grower

Greenblatt

Strong

Earnings yield 9.3% · ROC 72%

Frequently Asked Questions

Is Prestige Consumer Healthcare Inc. (PBH) a good investment?
As of Sep 20, 2026, Prestige Consumer Healthcare Inc. (PBH) scores 3.2/10 on AlphaStocks' five-model composite, #155 of 168 Health Care stocks. That score is below average, suggesting caution. Trades at 12x earnings — near sector median of 30x.
What is Prestige Consumer Healthcare Inc.'s Piotroski F-Score?
Prestige Consumer Healthcare Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is PBH overvalued or undervalued?
A precise fair value estimate is not available for PBH. Trades at 12x earnings — near sector median of 30x.
How does PBH compare to other Health Care stocks?
Prestige Consumer Healthcare Inc. ranks #155 out of 168 stocks in the Health Care sector, placing it in the top 92% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about PBH?
AlphaStocks evaluates PBH using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 3.2/10.

Similar Stocks

AMPHLLYACAD

Compare PBH with

AMPH vs PBHLLY vs PBHACAD vs PBHPARR vs PBHPBH vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer